CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: SPIDR (ImmuneEditome ID:23514)

1. Gene summary of enriched editing regions for SPIDR

check button Gene summary
Gene informationGene symbol

SPIDR

Gene ID

23514

GeneSynonymsKIAA0146|ODG9
GeneCytomap

8q11.21

GeneTypeprotein-coding
GeneDescriptionDNA repair-scaffolding protein|scaffolding protein involved in DNA repair
GeneModificationdate20230329
UniprotIDQ14159;E7EVI9;B4DMX9;B3KP42;E5RIB8;E5RJJ2;E5RHG3;E5RFY2;E5RIU7;E5RGX8;E5RGV8
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr8:47268966-47269487:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicAluSg,(T)n,AluJbchr8:47268966-47269487:+.alignment
chr8:47268966-47269487:+ENST00000522900.4ENSG00000164808.15SPIDRncRNA_intronicAluSg,(T)n,AluJbchr8:47268966-47269487:+.alignment
chr8:47268966-47269487:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicAluSg,(T)n,AluJbchr8:47268966-47269487:+.alignment
chr8:47322795-47323025:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicL1PA4chr8:47322795-47323025:+.alignment
chr8:47322795-47323025:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicL1PA4chr8:47322795-47323025:+.alignment
chr8:47322795-47323025:+ENST00000522900.4ENSG00000164808.15SPIDRncRNA_intronicL1PA4chr8:47322795-47323025:+.alignment
chr8:47322795-47323025:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicL1PA4chr8:47322795-47323025:+.alignment
chr8:47464958-47465532:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicL1PA13,AluSz,AluSxchr8:47464958-47465532:+.alignment
chr8:47464958-47465532:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicL1PA13,AluSz,AluSxchr8:47464958-47465532:+.alignment
chr8:47464958-47465532:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicL1PA13,AluSz,AluSxchr8:47464958-47465532:+.alignment
chr8:47529161-47529312:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluSc8chr8:47529161-47529312:+.alignment
chr8:47529161-47529312:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicAluSc8chr8:47529161-47529312:+.alignment
chr8:47529161-47529312:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicAluSc8chr8:47529161-47529312:+.alignment
chr8:47564232-47565244:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluSp,AluSx,AluScchr8:47564232-47565244:+.alignment
chr8:47564232-47565244:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicAluSp,AluSx,AluScchr8:47564232-47565244:+.alignment
chr8:47564232-47565244:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicAluSp,AluSx,AluScchr8:47564232-47565244:+.alignment
chr8:47575680-47576608:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluSx,AluSgchr8:47575680-47576608:+.alignment
chr8:47575680-47576608:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicAluSx,AluSgchr8:47575680-47576608:+.alignment
chr8:47575680-47576608:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicAluSx,AluSgchr8:47575680-47576608:+.alignment
chr8:47586782-47587443:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicL1MD1,AluSx,AluSzchr8:47586782-47587443:+.alignment
chr8:47586782-47587443:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicL1MD1,AluSx,AluSzchr8:47586782-47587443:+.alignment
chr8:47586782-47587443:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicL1MD1,AluSx,AluSzchr8:47586782-47587443:+.alignment
chr8:47706807-47708283:+ENST00000518692.1ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47706807-47708283:+ENST00000519141.4ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47706807-47708283:+ENST00000519362.4ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47706807-47708283:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47706807-47708283:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47706807-47708283:+ENST00000522321.4ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47706807-47708283:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicAluSx3,L1MD2,AluSz,MLT1C,AluSx1chr8:47706807-47708283:+.alignment
chr8:47709932-47710941:+ENST00000518692.1ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47709932-47710941:+ENST00000519141.4ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47709932-47710941:+ENST00000519362.4ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47709932-47710941:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47709932-47710941:+ENST00000521550.4ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47709932-47710941:+ENST00000522321.4ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47709932-47710941:+ENST00000524141.4ENSG00000164808.15SPIDRncRNA_intronicAluSz,AluJb,AluSpchr8:47709932-47710941:+.alignment
chr8:47729718-47731226:+ENST00000519141.4ENSG00000164808.15SPIDRncRNA_intronicAluJo,AluSxchr8:47729718-47731226:+.alignment
chr8:47729718-47731226:+ENST00000519362.4ENSG00000164808.15SPIDRncRNA_intronicAluJo,AluSxchr8:47729718-47731226:+.alignment
chr8:47729718-47731226:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluJo,AluSxchr8:47729718-47731226:+.alignment
chr8:47733083-47733361:+ENST00000519141.4ENSG00000164808.15SPIDRncRNA_intronicAluSxchr8:47733083-47733361:+.alignment
chr8:47733083-47733361:+ENST00000519362.4ENSG00000164808.15SPIDRncRNA_intronicAluSxchr8:47733083-47733361:+.alignment
chr8:47733083-47733361:+ENST00000521214.4ENSG00000164808.15SPIDRncRNA_intronicAluSxchr8:47733083-47733361:+.alignment
chr8:47733083-47733361:+ENST00000588781.1ENSG00000164808.15SPIDRncRNA_intronicAluSxchr8:47733083-47733361:+.alignment


Top

2. Tumor-specific enriched editing regions for SPIDR


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for SPIDR


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for SPIDR


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000164808.15,SPIDR
ESCAEAGMEXENSG00000172053.10chr349095993:49096079:49097991:49098480:49098549:49098692:49098884:49098989-0.45013.2504e-031.5422e-06-0.4145imageNACIN1;ADAR;AIFM1;ALYREF;BCCIP;BUD13;CELF2;CNBP;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DKC1;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP4B;LARP7;LIN28A;LIN28B;LSM11;MOV10;MSI1;MSI2;NOP56;NOP58;NPM1;PCBP2;PRPF8;PTBP1;QKI;RBFOX2;RBM10;RBM22;RBM5;SAFB2;SF3A3;SF3B4;SLBP;SMNDC1;SND1;SRSF1;SRSF10;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TNRC6A;TROVE2;U2AF2;UPF1;VIM;YTHDC1;YTHDF1;YWHAG;ZNF184NAT_cells_CD8GSVA_HALLMARK_MITOTIC_SPINDLE

More results



Top

5. Enriched editing regions and immune infiltration for SPIDR


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
ENSG00000164808.15,SPIDRBLCAEAGMacrophages_M01.0757e-020.4258image
chr8:47729718-47731226:+BRCAEERT_cells_CD4_memory_activated1.2493e-020.1819image
ENSG00000164808.15,SPIDRBRCAEAGDendritic_cells_resting2.5098e-020.1568image
chr8:47729718-47731226:+CESCEERT_cells_gamma_delta4.7716e-02-0.4081image
ENSG00000164808.15,SPIDRCOADEAGT_cells_CD83.1879e-020.4692image
chr8:47706807-47708283:+ESCAEERMacrophages_M13.8295e-020.4548image
chr8:47729718-47731226:+ESCAEERMacrophages_M24.3202e-020.1987image
ENSG00000164808.15,SPIDRESCAEAGMacrophages_M11.8056e-020.2112image
ENSG00000164808.15,SPIDRHNSCEAGNK_cells_activated3.8952e-03-0.6018image
chr8:47729718-47731226:+KIRCEERDendritic_cells_activated3.5471e-020.2952image
ENSG00000164808.15,SPIDRKIRCEAGDendritic_cells_activated2.0924e-020.3166image
chr8:47729718-47731226:+LAMLEERT_cells_CD4_memory_resting8.1606e-040.3218image
ENSG00000164808.15,SPIDRLAMLEAGT_cells_CD4_memory_resting2.8726e-030.2556image
ENSG00000164808.15,SPIDRLUADEAGEosinophils5.0138e-03-0.2515image
chr8:47729718-47731226:+LUSCEERMacrophages_M12.3157e-02-0.2064image
ENSG00000164808.15,SPIDRLUSCEAGNK_cells_resting2.7193e-020.1984image
chr8:47729718-47731226:+OVEERT_cells_regulatory_(Tregs)3.1150e-030.3152image
ENSG00000164808.15,SPIDROVEAGEosinophils2.2553e-030.2763image
chr8:47529161-47529312:+STADEERT_cells_regulatory_(Tregs)4.2517e-02-0.4575image
chr8:47575680-47576608:+STADEERNK_cells_activated5.6516e-040.7017image
chr8:47586782-47587443:+STADEERT_cells_gamma_delta4.8437e-030.4316image
chr8:47706807-47708283:+STADEERDendritic_cells_activated1.4479e-020.3704image
chr8:47729718-47731226:+STADEERT_cells_CD81.3544e-02-0.2054image
ENSG00000164808.15,SPIDRSTADEAGT_cells_CD81.2518e-02-0.1750image
chr8:47729718-47731226:+TGCTEERT_cells_CD83.3951e-020.4437image
ENSG00000164808.15,SPIDRTGCTEAGT_cells_CD83.3951e-020.4437image
ENSG00000164808.15,SPIDRTHCAEAGDendritic_cells_resting1.6009e-020.4963image


Top

6. Enriched editing regions and immune gene sets for SPIDR


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000164808.15,SPIDRBLCAGSVA_HALLMARK_APICAL_JUNCTIONEAG1.2181e-020.4192image
ENSG00000164808.15,SPIDRBRCAGSVA_HALLMARK_FATTY_ACID_METABOLISMEAG1.0507e-060.3340image
chr8:47729718-47731226:+BRCAGSVA_HALLMARK_FATTY_ACID_METABOLISMEER3.6017e-040.2575image
ENSG00000164808.15,SPIDRCESCGSVA_HALLMARK_MITOTIC_SPINDLEEAG1.5296e-020.4538image
ENSG00000164808.15,SPIDRCOADGSVA_HALLMARK_XENOBIOTIC_METABOLISMEAG8.4846e-060.8103image
ENSG00000164808.15,SPIDRESCAGSVA_HALLMARK_BILE_ACID_METABOLISMEAG3.9137e-040.3123image
chr8:47729718-47731226:+ESCAGSVA_HALLMARK_MITOTIC_SPINDLEEER1.2319e-02-0.2446image
ENSG00000164808.15,SPIDRHNSCGSVA_HALLMARK_UV_RESPONSE_DNEAG3.2073e-020.4688image
ENSG00000164808.15,SPIDRKIRCGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEAG4.5688e-030.3837image
chr8:47729718-47731226:+KIRCGSVA_HALLMARK_HYPOXIAEER9.2006e-030.3612image
ENSG00000164808.15,SPIDRLAMLGSVA_HALLMARK_DNA_REPAIREAG2.9183e-040.3082image
chr8:47729718-47731226:+LAMLGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEER1.9477e-02-0.2277image
chr8:47729718-47731226:+LUADGSVA_HALLMARK_NOTCH_SIGNALINGEER1.1279e-020.2355image
ENSG00000164808.15,SPIDRLUADGSVA_HALLMARK_NOTCH_SIGNALINGEAG3.7517e-050.3627image
ENSG00000164808.15,SPIDROVGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG8.4181e-040.3008image
ENSG00000164808.15,SPIDRPRADGSVA_HALLMARK_UNFOLDED_PROTEIN_RESPONSEEAG1.0857e-050.7699image
ENSG00000164808.15,SPIDRSKCMGSVA_HALLMARK_PI3K_AKT_MTOR_SIGNALINGEAG1.1817e-020.5509image
chr8:47529161-47529312:+STADGSVA_HALLMARK_ANDROGEN_RESPONSEEER2.2357e-020.5075image
chr8:47729718-47731226:+STADGSVA_HALLMARK_BILE_ACID_METABOLISMEER4.4520e-020.1677image
chr8:47706807-47708283:+STADGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEER7.3040e-03-0.4034image
chr8:47586782-47587443:+STADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.6294e-030.4441image
ENSG00000164808.15,SPIDRSTADGSVA_HALLMARK_HYPOXIAEAG1.2757e-030.2246image
ENSG00000164808.15,SPIDRTGCTGSVA_HALLMARK_HEME_METABOLISMEAG3.7166e-020.4368image
chr8:47729718-47731226:+TGCTGSVA_HALLMARK_HEME_METABOLISMEER3.7166e-020.4368image
ENSG00000164808.15,SPIDRTHCAGSVA_HALLMARK_MYC_TARGETS_V2EAG4.8817e-04-0.6685image


Top

7. Enriched editing regions and drugs for SPIDR


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000164808.15,SPIDRBLCABMS.754807EAG2.7921e-020.3717image
ENSG00000164808.15,SPIDRBRCAIPA.3EAG1.0137e-050.3036image
chr8:47729718-47731226:+BRCABMS.509744EER2.3289e-03-0.2208image
chr8:47729718-47731226:+CESCBMS.708163EER6.2467e-030.5418image
ENSG00000164808.15,SPIDRCESCCI.1040EAG2.6883e-030.5454image
ENSG00000164808.15,SPIDRCOADABT.263EAG1.1191e-040.7436image
ENSG00000164808.15,SPIDRESCACHIR.99021EAG3.5871e-04-0.3142image
chr8:47729718-47731226:+ESCAFH535EER1.9106e-02-0.2295image
ENSG00000164808.15,SPIDRHNSCA.443654EAG3.9338e-030.6013image
ENSG00000164808.15,SPIDRKIRCAG.014699EAG4.6290e-030.3832image
chr8:47729718-47731226:+KIRCAG.014699EER1.5015e-020.3388image
ENSG00000164808.15,SPIDRLAMLGW843682XEAG2.6272e-05-0.3546image
chr8:47729718-47731226:+LAMLDoxorubicinEER9.6375e-04-0.3176image
ENSG00000164808.15,SPIDRLGGGefitinibEAG6.0421e-030.4895image
chr8:47729718-47731226:+LGGGefitinibEER6.0421e-030.4895image
chr8:47729718-47731226:+LUADFH535EER7.6381e-03-0.2476image
ENSG00000164808.15,SPIDRLUADBMS.708163EAG2.2794e-040.3265image
chr8:47729718-47731226:+LUSCBI.D1870EER9.7851e-030.2340image
ENSG00000164808.15,SPIDRLUSCABT.888EAG2.1824e-020.2058image
ENSG00000164808.15,SPIDROVBAY.61.3606EAG1.1561e-03-0.2932image
chr8:47729718-47731226:+OVABT.263EER4.9316e-030.3005image
ENSG00000164808.15,SPIDRPRADAG.014699EAG7.2004e-040.6420image
ENSG00000164808.15,SPIDRSKCMJNK.Inhibitor.VIIIEAG1.4317e-02-0.5384image
chr8:47529161-47529312:+STADCI.1040EER4.0995e-02-0.4606image
chr8:47564232-47565244:+STADCCT018159EER3.1643e-030.5291image
chr8:47729718-47731226:+STADBMS.708163EER4.5504e-030.2352image
chr8:47706807-47708283:+STADDocetaxelEER2.3344e-02-0.3453image
chr8:47575680-47576608:+STADAMG.706EER3.5861e-03-0.6194image
ENSG00000164808.15,SPIDRSTADBMS.708163EAG9.1497e-030.1825image
ENSG00000164808.15,SPIDRTGCTCGP.082996EAG5.6415e-03-0.5582image
chr8:47729718-47731226:+TGCTCGP.082996EER5.6415e-03-0.5582image
ENSG00000164808.15,SPIDRTHCAImatinibEAG3.5491e-02-0.4403image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType